COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 110 filers reported holding COHERUS BIOSCIENCES INC in Q3 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $189,000 | +19.6% | 11,775 | +2.8% | 0.00% | – |
| Q2 2021 | $158,000 | -5.4% | 11,450 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $167,000 | -16.1% | 11,450 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $199,000 | -5.2% | 11,450 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $210,000 | +2.4% | 11,450 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $205,000 | +10.8% | 11,450 | -0.7% | 0.00% | 0.0% |
| Q1 2020 | $185,000 | -10.6% | 11,530 | +0.1% | 0.00% | 0.0% |
| Q4 2019 | $207,000 | -21.6% | 11,524 | -11.8% | 0.00% | 0.0% |
| Q3 2019 | $264,000 | -1.5% | 13,068 | +7.3% | 0.00% | -50.0% |
| Q2 2019 | $268,000 | +71.8% | 12,184 | +6.4% | 0.00% | +100.0% |
| Q1 2019 | $156,000 | +50.0% | 11,450 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $104,000 | -39.2% | 11,450 | +10.6% | 0.00% | 0.0% |
| Q3 2018 | $171,000 | +17.9% | 10,350 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $145,000 | +27.2% | 10,350 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $114,000 | – | 10,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 200,000 | $1,448,000 | 1.54% |
| Tri Locum Partners LP | 376,486 | $2,726,000 | 1.12% |
| Perceptive Advisors | 3,645,471 | $26,393,000 | 0.83% |
| TANG CAPITAL MANAGEMENT LLC | 750,000 | $5,430,000 | 0.82% |
| Bridge City Capital, LLC | 162,146 | $1,174,000 | 0.62% |
| Knott David M Jr | 186,134 | $1,348,000 | 0.57% |
| Aristotle Capital Boston, LLC | 2,322,168 | $16,812,000 | 0.50% |
| Phocas Financial Corp. | 316,455 | $2,291,000 | 0.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $22,644,000 | 0.30% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $53,439,280 | 0.29% |